Investigation of Serotonergic Signaling Mechanisms that Promote Regeneration Following Spinal Cord Injury
Research Grant Recipient: Jacob Montgomery, PhD
Award Value: $250,000
Research Focus: Spinal Cord Injury
From the Investigator:
CELLTOP: A Phase I Clinical Trial of Autologous Adipose Derived Mesenchymal Stem Cells in the Treatment of Paralysis due to Traumatic Spinal Cord Injury
Restoring function to paralyzed limbs after spinal cord injury
Paralysis due to spinal cord injury is currently an untreatable condition. Current treatments include stabalizing the patient and then strengthening the muscles above the site of paralysis. Grahn's research seeks to restore function in paralyzed muscles through controlled spinal cord stimulation.